Valuation: Cegedim

Market Cap 146M 168M 136M 124M 234M 16.03B 238M 1.61B 627M 8.02B 630M 617M 26.76B P/E 2026 *
6.95x
P/E 2027 * 5.3x
Enterprise Value 308M 355M 288M 263M 495M 33.88B 503M 3.4B 1.33B 16.96B 1.33B 1.3B 56.57B EV / Sales 2026 *
0.47x
EV / Sales 2027 * 0.41x
Free-Float
36.52%
Yield 2026 *
-
Yield 2027 * -
1 day-14.57%
1 week+19.35%
Current month+19.35%
1 month+14.62%
3 months+12.08%
6 months-7.60%
Current year-9.33%
1 week 10.4
Extreme 10.4
12.15
1 month 10.12
Extreme 10.12
12.15
Current year 8.6
Extreme 8.6
14.8
1 year 8.6
Extreme 8.6
14.8
3 years 8.6
Extreme 8.6
21.05
5 years 8.6
Extreme 8.6
29
10 years 8.6
Extreme 8.6
42.5
Manager TitleAgeSince
Chief Executive Officer 83 2009-10-24
Director of Finance/CFO - 2016-06-13
Corporate Officer/Principal 55 2015-11-25
Director TitleAgeSince
Chairman 83 2009-10-24
Director/Board Member 72 2010-08-08
Director/Board Member 55 2009-10-25
Change 5-day change 1-year change 3-year change Capi.($)
-56.91%+19.35% - - 168M
+0.31%+7.26%-36.98%+33.15% 442B
-0.33%+2.57%-26.62%+37.94% 234B
-1.04%+5.16%-28.53%+8.97% 129B
+0.64%-2.83%-30.74%+15.62% 46.82B
+0.17%-1.84%-75.62%+144.50% 36.44B
+2.61%+3.60%-19.94%+22.08% 22.55B
+0.95%-1.02%-22.48%+45.61% 19.69B
+1.29%+9.50%-16.16%+110.56% 14.41B
-0.82%-4.97%-34.13%+0.22% 13.14B
Average -0.99%+0.95%-32.36%+46.52% 106.46B
Weighted average by Cap. +0.11%+4.37%-33.42%+35.15%

Financials

2026 *2027 *
Net sales 660M 761M 618M 564M 1.06B 72.62B 1.08B 7.28B 2.84B 36.35B 2.86B 2.79B 121B 684M 789M 641M 585M 1.1B 75.32B 1.12B 7.55B 2.95B 37.7B 2.96B 2.9B 126B
Net income 21.3M 24.57M 19.97M 18.21M 34.26M 2.35B 34.81M 235M 91.79M 1.17B 92.25M 90.26M 3.92B 28M 32.3M 26.25M 23.93M 45.03M 3.08B 45.75M 309M 121M 1.54B 121M 119M 5.15B
Net Debt 162M 187M 152M 139M 261M 17.85B 265M 1.79B 699M 8.94B 702M 687M 29.81B 134M 154M 125M 114M 215M 14.73B 219M 1.48B 576M 7.37B 579M 567M 24.59B
Logo Cegedim
Cegedim is a European leading in collecting, processing, and distributing data and services related to medical information. Net sales break down by market as follows: - Insurance companies and services (73.4%): computerization of insurers and mutual benefit insurance companies, management of third-party payers and health care trends, external human resources management, computer and Internet services, etc. The group also develops processing sales statistics of pharmaceutical products, management of medical samples and promotional materials activities, etc. (GERS); - Health care professionals (20.6%): software for physicians and pharmacists, pharmaceutical data base, scientific, medical, and promotional information, etc.; - other (6%). France accounts for 91.9% of net sales.
Employees
6,344
Date Price Change Volume
26-08-11 €10.40 -3.35% 1
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
10.60EUR
Average target price
15.50EUR
Spread / Average Target
+46.23%

Quarterly revenue - Rate of surprise